Mirum Pharmaceuticals, Inc. (MIRM) key performance indicators and operating metrics (3 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Livmarli Global Net Product Sales | 113.8M | FY2026-Q1 |
| Global Net Product Sales | 159.9M | FY2026-Q1 |
| Bile Acid Medicines Net Product Sales | 46.1M | FY2026-Q1 |
Back to MIRM overview · MIRM earnings · MIRM holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.